X
Addressing MS’ two-tier healthcare system is about ‘social justice’
https://pharmaphorum.com/views-analysis-patients/ms-two-tier-healthcare-system/
MS
‘Listen to your patients’: the best MS care honoured at QuDoS
Best healthcare professionals working in multiple sclerosis (MS) honoured QuDoS awards.
5 questions: making Multiple Sclerosis care more patient-centric
Trishna Bharadia, Multiple Sclerosis patient advocate, wants to make MS care more patient-centric.
Addressing the growing need for better Multiple Sclerosis care
Jo Sopala of the MS Trust describes the organisation’s work in creating better multiple sclerosis care.
Multiple sclerosis: A patient’s perspective
A patient’s view of the challenges facing people with multiple sclerosis.
FDA delays decision on key Roche MS drug
FDA to review new manufacturing data.
Novartis drug effective in advanced MS
Siponimod slowed disability progression in secondary progressive multiple sclerosis
After 2015’s ‘breakthrough’ year for pharma approvals, will 2016 see a dip?
Roche’s MS drug is among major drugs still to come in 2016.
1 2